NICE's QALY approach 'flawed'


Research funded by the European Commission has claimed the quality adjusted life years approach to deciding which treatments are made available by health services is “dangerously flawed”.

You need to be signed in to read more


Subscribe for unlimited access

With a HSJ subscription you’ll unlock:

  • All of and our HSJ mobile app
  • News and insight on all areas of public funded healthcare
  • Expert commentary, insight and analysis from industry leaders
  • 9 weekly ‘Expert Briefing’ insight emails covering a variety of specialist topics

Sign into your account here